All translations

Jump to navigation Jump to search

Enter a message name below to show all available translations.

Message

Found 2 translations.

NameCurrent message text
 h English (en){| class="wikitable" style="float: right; margin-left: 2em;"
|+ Dietary recommendations
|
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | Australia and New Zealand
|-
! scope="col" style="width:8em" | Age group
! scope="col" style="width:8em" | RDI for niacin (mg NE/day)
! scope="col" style="width:8em" | Upper level of intake
|-
| Infants 0–6 months || 2 mg/d preformed niacin* || rowspan="2"| ND
|-
| Infants 7–12 months || 4 mg/d NE*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| 14–18 || – || 30
|-
| 19+ || – || 35
|-
| Females 14+ || 14 || rowspan=2 | –
|-
| Males 14+ || 16
|-
| Pregnant females 14–50 || 18 || –
|-
| Pregnant females 14–18 || – || 30
|-
| Pregnant females 19–50 || – || 35
|-
| Lactating females 14–50 || 17 || –
|-
| Lactating females 14–18 || – || 30
|-
| Lactating females 19–50 || – || 35
|-
| colspan="3" style="text-align: center;" | * Adequate Intake for infants
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | Canada
|-
! scope="col" style="width:8em" | Age group (years)
! scope="col" style="width:8em" | RDA of niacin (mg NE/d)
! scope="col" style="width:8em" | Tolerable upper intake level
|-
| 0–6 months || 2 mg/d preformed niacin* || rowspan=2| ND
|-
| 7–12 months || 4 mg/d NE*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| Females 14–18 || 14 || rowspan=2| 30
|-
| Males 14–18 || 16
|-
| Females 19+ || 14 || rowspan=2| 35
|-
| Males 19+ || 16
|-
| Pregnant females <18 || 18 || 30
|-
| Pregnant females 18–50 || 18 || 35
|-
| Lactating females <18 || 17 || 30
|-
| Lactating females 18–50 || 17 || 35
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | European Food Safety Authority
|-
! scope="col" width=8em | Gender
! colspan=2 width=16em | Adequate Intake (mg NE/MJ)
|-
| Females || colspan=2 width="8em"| 1.3
|-
| Males || colspan=2 width="8em"| 1.6
|-
! scope="col" style="width:8em" | Age (years)
! scope="col" style="width:8em" | Tolerable upper limit of Nicotinic acid (mg/day)
! scope="col" style="width:8em" | Tolerable upper limit of Nicotinamide (mg/day)
|-
| 1–3 || 2 || 150
|-
| 4–6 || 3 || 220
|-
| 7–10 || 4 || 350
|-
| 11–14 || 6 || 500
|-
| 15–17 || 8 || 700
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | United States
|-
! scope="col" style="width:8em" | Age group
! scope="col" style="width:8em" | RDA for niacin (mg NE/day)
! scope="col" style="width:8em" | Tolerable upper intake level
|-
| Infants 0–6 months || 2* || rowspan="2"| ND**
|-
| Infants 6–12 months || 4*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| Females 14–18 || 14 || 30
|-
| Males 14–18 || 16 || 30
|-
| Females 19+ || 14 || 35
|-
| Males 19+ || 16 || 35
|-
| Pregnant females 14–18 || 18 || 30
|-
| Pregnant females 19–50 || 18 || 35
|-
| Lactating females 14–18 || 17 || 30
|-
| Lactating females 19–50 || 17 || 35
|-
| colspan="3" style="text-align: center;" | * Adequate intake for infants, as an RDA has yet to be established<br />** Not possible to establish; source of intake should be formula and food only
|-
|}
|}
The U.S. Institute of Medicine (renamed [[National Academy of Medicine]] in 2015) updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for niacin in 1998, as well as [[Tolerable upper intake levels]] (ULs). In lieu of an RDA, Adequate Intakes (AIs) are identified for populations for which there is not enough evidence to identify a dietary intake level that is sufficient to meet the nutrient requirements of most people. (see table).
 h Japanese (ja){| class="wikitable" style="float: right; margin-left: 2em;"
|+ 食事に関する推奨事項
|
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | オーストラリアとニュージーランド
|-
! scope="col" style="width:8em" | 年齢層
! scope="col" style="width:8em" | ナイアシンのRDI (mg NE/day)
! scope="col" style="width:8em" | 摂取量の上限レベル
|-
| 幼児 0–6ヶ月 || 2&nbsp;mg/d プリフォームド・ナイアシン* || rowspan="2"| ND
|-
| 幼児 7–12ヶ月 || 4&nbsp;mg/d NE*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| 14–18 || – || 30
|-
| 19+ || – || 35
|-
| 女性 14+ || 14 || rowspan=2 | –
|-
| 男性 14+ || 16
|-
| 妊娠中の女性 14–50 || 18 || –
|-
| 妊娠中の女性 14–18 || – || 30
|-
| 妊娠中の女性 19–50 || – || 35
|-
| 授乳中の女性 14–50 || 17 || –
|-
| 授乳中の女性 14–18 || – || 30
|-
| 授乳中の女性 19–50 || – || 35
|-
| colspan="3" style="text-align: center;" | * 乳児の適切な摂取量
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | カナダ
|-
! scope="col" style="width:8em" | 年齢層（歳）
! scope="col" style="width:8em" | ナイアシンのRDA （mg NE/d）
! scope="col" style="width:8em" | 許容上限摂取量
|-
| 0–6 months || 2&nbsp;mg/d プリフォームド・ナイアシン* || rowspan=2| ND
|-
| 7–12ヶ月 || 4&nbsp;mg/d NE*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| 女性 14–18 || 14 || rowspan=2| 30
|-
| 男性 14–18 || 16
|-
| 女性 19+ || 14 || rowspan=2| 35
|-
| 男性 19+ || 16
|-
| 妊娠中の女性 <18 || 18 || 30
|-
| 妊娠中の女性 18–50 || 18 || 35
|-
| 授乳中の女性 <18 || 17 || 30
|-
| 授乳中の女性 18–50 || 17 || 35
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | 欧州食品安全機関
|-
! scope="col" width=8em | 性別
! colspan=2 width=16em | 十分な摂取量 （mg NE/MJ）
|-
| 女性 || colspan=2 width="8em"| 1.3
|-
| 男性 || colspan=2 width="8em"| 1.6
|-
! scope="col" style="width:8em" | 年齢 （歳）
! scope="col" style="width:8em" | ニコチン酸の許容上限値 （mg/day）
! scope="col" style="width:8em" | ニコチンアミドの耐容上限量 （mg/day）
|-
| 1–3 || 2 || 150
|-
| 4–6 || 3 || 220
|-
| 7–10 || 4 || 350
|-
| 11–14 || 6 || 500
|-
| 15–17 || 8 || 700
|-
|}
{| class="wikitable mw-collapsible mw-collapsed" style="font-size: 80%; text-align: center; width:406px"
|-
|+ style="background: blue; color: white; font-size: 110%; text-align: center;" | 米国
|-
! scope="col" style="width:8em" | 年齢層
! scope="col" style="width:8em" | ナイアシンのRDA (mg NE/day)
! scope="col" style="width:8em" | 許容上限摂取量
|-
| 幼児 0–6ヶ月 || 2* || rowspan="2"| ND**
|-
| 幼児 6–12ヶ月 || 4*
|-
| 1–3 || 6 || 10
|-
| 4–8 || 8 || 15
|-
| 9–13 || 12 || 20
|-
| 女性 14–18 || 14 || 30
|-
| 男性 14–18 || 16 || 30
|-
| 女性 19+ || 14 || 35
|-
| 男性 19+ || 16 || 35
|-
| 妊娠中の女性 14–18 || 18 || 30
|-
| 妊娠中の女性 19–50 || 18 || 35
|-
| 授乳中の女性 14–18 || 17 || 30
|-
| 授乳中の女性 19–50 || 17 || 35
|-
| colspan="3" style="text-align: center;" | * RDA はまだ確立されていないため、乳児の十分な摂取量<br />** 確立は不可能である； 
摂取源は粉ミルクと食事のみとする。
|-
|}
|}
米国医学研究所（2015年に[[:en:National Academy of Medicine|米国医学アカデミー]]に改称）は、1998年にナイアシンの推定平均必要量（EAR）と推奨食事許容量（RDA）、および[[耐容上限摂取量レベル]]（UL）を更新した。RDAの代わりに、ほとんどの人々の栄養所要量を満たすのに十分な食事摂取レベルを特定するのに十分な証拠がない集団については、十分摂取量（AAI）が特定される。（表参照）。
Retrieved from "https://wiki.tiffa.net/wiki/Special:Translations"